Asmae Chadli1, Siham El Aziz1, Nawal El Ansari2, Farida Ajdi3, Mehdi Seqat4, Hanane Latrech5, Ghizlaine Belmejdoub6. 1. Ibn Rushd University Hospital, Casablanca, Morocco. 2. Mohammed VI University Hospital, Marrakesh, Morocco. 3. Hassan II University Hospital, Fez, Morocco. 4. Sanofi Maroc, Casablanca, Morocco. 5. Mohamed VI University Hospital, Oujda, Morocco. 6. Military Hospital Instruction Mohammed V, Rabat, Morocco.
Abstract
OBJECTIVES: The International Diabetes Mellitus Practice Study (IDMPS) is a 5-year survey documenting changes in diabetes treatment practices in developing countries. The primary objective of this survey was to assess the therapeutic management of type 2 diabetes mellitus (T2DM) in real-life medical practice. The secondary objectives were to evaluate the clinical management of type 1 diabetes mellitus (T1DM) and to assess the proportion of all diabetic patients failing to reach the glycated haemoglobin (HbA1c) <7% target. METHODS: Data were analysed for 738 patients (240 with T1DM and 498 with T2DM) included in wave 5 of the IDMPS in Morocco in 2011. RESULTS: Nearly two-thirds (61%) of T2DM patients were treated with oral glucose-lowering drugs (OGLDs) alone, 13.1% were treated with insulin alone and 23.3% were treated with OGLDs plus insulin. Insulin use was less frequent, was initiated later and involved a greater use of premixes versus basal/prandial schedules compared to other populations evaluated in the IDMPS. The majority (92.5%) of T1DM patients were treated with insulin alone and the remainder received insulin plus an OGLD. Insulin protocols included basal + prandial dosing (37.5%) and premix preparations (41.3%). The recommended target of HbA1c <7% was achieved by only 22.2% of T1DM patients and 26.8% of T2DM patients. More macrovascular but fewer microvascular complications were reported in T2DM compared to T1DM patients. Late complications increased with disease duration so that 20 years after diagnosis, 75.7% of T2DM patients were found to have at least one late complication. CONCLUSIONS: The clinical burden of diabetes is high in Morocco and the majority of patients do not achieve the recommended glycaemia target, suggesting that there is a huge gap between evidence-based diabetic management and real-life practice. Better education of patients and improved compliance with international recommendations are necessary to deliver a better quality of diabetic care.
OBJECTIVES: The International Diabetes Mellitus Practice Study (IDMPS) is a 5-year survey documenting changes in diabetes treatment practices in developing countries. The primary objective of this survey was to assess the therapeutic management of type 2 diabetes mellitus (T2DM) in real-life medical practice. The secondary objectives were to evaluate the clinical management of type 1 diabetes mellitus (T1DM) and to assess the proportion of all diabeticpatients failing to reach the glycated haemoglobin (HbA1c) <7% target. METHODS: Data were analysed for 738 patients (240 with T1DM and 498 with T2DM) included in wave 5 of the IDMPS in Morocco in 2011. RESULTS: Nearly two-thirds (61%) of T2DM patients were treated with oral glucose-lowering drugs (OGLDs) alone, 13.1% were treated with insulin alone and 23.3% were treated with OGLDs plus insulin. Insulin use was less frequent, was initiated later and involved a greater use of premixes versus basal/prandial schedules compared to other populations evaluated in the IDMPS. The majority (92.5%) of T1DM patients were treated with insulin alone and the remainder received insulin plus an OGLD. Insulin protocols included basal + prandial dosing (37.5%) and premix preparations (41.3%). The recommended target of HbA1c <7% was achieved by only 22.2% of T1DM patients and 26.8% of T2DM patients. More macrovascular but fewer microvascular complications were reported in T2DM compared to T1DM patients. Late complications increased with disease duration so that 20 years after diagnosis, 75.7% of T2DM patients were found to have at least one late complication. CONCLUSIONS: The clinical burden of diabetes is high in Morocco and the majority of patients do not achieve the recommended glycaemia target, suggesting that there is a huge gap between evidence-based diabetic management and real-life practice. Better education of patients and improved compliance with international recommendations are necessary to deliver a better quality of diabetic care.
Authors: J J Gagliardino; P Aschner; S H Baik; J Chan; J M Chantelot; H Ilkova; A Ramachandran Journal: Diabetes Metab Date: 2011-10-22 Impact factor: 6.041
Authors: L Guariguata; D R Whiting; I Hambleton; J Beagley; U Linnenkamp; J E Shaw Journal: Diabetes Res Clin Pract Date: 2013-12-01 Impact factor: 5.602
Authors: Fernando J Lavalle-González; Erwin Chiquete; Julieta de la Luz; Ana Ochoa-Guzmán; Laura V Sánchez-Orozco; Sergio A Godínez-Gutiérrez Journal: Endocrinol Nutr Date: 2012-11-06
Authors: Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Paolo Chiodini; Antonio Ceriello; Katherine Esposito Journal: Diabetes Care Date: 2011-01-07 Impact factor: 19.112
Authors: Ahmed O Almobarak; Sufian K Noor; Wadie M Elmadhoun; Sarra O Bushara; Reham S Salim; Sittana A Forawi; Heitham Awadalla; Einas S Elwali; Mohamed H Ahmed Journal: J Family Med Prim Care Date: 2017 Apr-Jun
Authors: Ahmed Chetoui; Kamal Kaoutar; Soufiane Elmoussaoui; Kaltoum Boutahar; Abdesslam El Kardoudi; Fatiha Chigr; Mohamed Najimi Journal: Int Health Date: 2020-01-20 Impact factor: 3.131